RRM Outcomes: Published Evidence documents the live birth rates achieved by Restorative Reproductive Medicine and NaProTECHNOLOGY in peer-reviewed literature. Several key studies characterize outcomes across diverse infertility populations.
Boyle et al. (2025, Journal of Restorative Reproductive Medicine, n=187, NeoFertility Dublin) reported a crude live birth rate of 41%, with a preterm birth rate in singletons of 4.0%. Sanchez-Mendez et al. (2025, Frontiers in Reproductive Health, n=1,310) reported a crude live birth rate of 35.3% and adjusted cumulative rates of 50.0% at 24 months and 62.1% at 36 or more months. Stanford et al. (2021, BMC Pregnancy and Childbirth) reported a cumulative live birth rate of 29% at 24 months in a primary infertility population, rising to 34% for women under age 35. Stanford et al. (2022, Human Reproduction Open) followed the iNEST cohort of 843 couples over three years and reported a 57% pregnancy rate and a 44.2% live birth rate. Tham et al. (2012, Canadian Family Physician, n=108) reported an adjusted cumulative live birth rate of 66% at 24 months.
These rates compare favorably to IVF. The UK's Human Fertilisation and Embryology Authority reported an average IVF birth rate of 30% per embryo transferred in 2024, rising to 38% for patients aged 18 to 34, while RRM studies document significantly lower preterm birth and multiple birth rates. The evidence base reflects outcomes achieved by identifying and treating root causes in both partners rather than bypassing reproductive physiology.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.